About
Contact & Profiles
A5084108105
Research Areas
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- Ferroptosis and cancer prognosis
PLA Academy of Military Science
2023
Abstract Background Triple‐negative breast cancer (TNBC) is the most aggressive type of cancer. Immune checkpoint inhibitors (ICIs) have been widely used to treat various tumors and changed landscape tumor management, but data from real‐world studies ICIs for TNBC treatment remain limited. The aim this study was evaluate efficacy in patients with advanced a setting explore possible correlates. Methods clinical who received ICI Chinese People's Liberation Army (PLA) General Hospital were...
10.1002/cai2.70
article
EN
cc-by
Cancer Innovation
2023-04-23
Coming Soon ...